Therma Bright Inc
Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical he… Read more
Therma Bright Inc (TBRIF) - Net Assets
Latest net assets as of October 2025: $-1.52 Million USD
Based on the latest financial reports, Therma Bright Inc (TBRIF) has net assets worth $-1.52 Million USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($406.59K) and total liabilities ($1.92 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.52 Million |
| % of Total Assets | -373.07% |
| Annual Growth Rate | N/A |
| 5-Year Change | -219.04% |
| 10-Year Change | N/A |
| Growth Volatility | 1140.16 |
Therma Bright Inc - Net Assets Trend (2018–2025)
This chart illustrates how Therma Bright Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Therma Bright Inc (2018–2025)
The table below shows the annual net assets of Therma Bright Inc from 2018 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-07-31 | $-1.57 Million | -218.22% |
| 2024-07-31 | $1.32 Million | +2856.62% |
| 2023-07-31 | $44.79K | -98.37% |
| 2022-07-31 | $2.75 Million | +108.87% |
| 2021-07-31 | $1.32 Million | +487.24% |
| 2020-07-31 | $223.97K | +178.20% |
| 2019-07-31 | $-286.40K | -300.04% |
| 2018-07-31 | $-71.59K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Therma Bright Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2610199300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (July 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $41.01 Million | % |
| Total Equity | $-1.57 Million | 100.00% |
Therma Bright Inc Competitors by Market Cap
The table below lists competitors of Therma Bright Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
INCYTE
BE:ICY
|
$851.44K |
|
Tres-Or Resources Ltd
PINK:TRSFF
|
$851.51K |
|
JLT Mobile Computers AB (publ)
ST:JLT
|
$851.70K |
|
Golden Independence Mining Corp
OTCQB:GIDMF
|
$851.75K |
|
1606 Corp.
PINK:CBDW
|
$850.32K |
|
Star Pacific Tbk
JK:LPLI
|
$850.31K |
|
Murano Global Investments PLC Ordinary Shares
NASDAQ:MRNO
|
$849.95K |
|
ESTEE LAUDER-A
BE:ELAA
|
$849.59K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Therma Bright Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,324,023 to -1,565,917, a change of -2,889,940 (-218.3%).
- Net loss of 4,342,907 reduced equity.
- New share issuances of 174,900 increased equity.
- Other factors increased equity by 1,278,067.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-4.34 Million | -277.34% |
| Share Issuances | $174.90K | +11.17% |
| Other Changes | $1.28 Million | +81.62% |
| Total Change | $- | -218.27% |
Book Value vs Market Value Analysis
This analysis compares Therma Bright Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-07-31 | $0.00 | $0.02 | x |
| 2019-07-31 | $0.00 | $0.02 | x |
| 2020-07-31 | $0.00 | $0.02 | x |
| 2021-07-31 | $0.01 | $0.02 | x |
| 2022-07-31 | $0.01 | $0.02 | x |
| 2023-07-31 | $0.00 | $0.02 | x |
| 2024-07-31 | $0.02 | $0.02 | x |
| 2025-07-31 | $-0.03 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Therma Bright Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5410.44%
- • Asset Turnover: 0.32x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-1218.18%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | -8769.54% | 0.04x | 0.00x | $-1.23 Million |
| 2019 | 0.00% | -6110.51% | 0.08x | 0.00x | $-393.29K |
| 2020 | -279.81% | -16565.74% | 0.00x | 5.13x | $-649.08K |
| 2021 | -654.67% | -221744.06% | 0.00x | 1.70x | $-8.74 Million |
| 2022 | -214.08% | -4218.03% | 0.03x | 1.46x | $-6.16 Million |
| 2023 | -8411.71% | -15765.40% | 0.01x | 49.33x | $-3.77 Million |
| 2024 | -185.14% | -9402.79% | 0.01x | 2.41x | $-2.58 Million |
| 2025 | 0.00% | -5410.44% | 0.32x | 0.00x | $-4.19 Million |
Industry Comparison
This section compares Therma Bright Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Therma Bright Inc (TBRIF) | $-1.52 Million | 0.00% | N/A | $851.27K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |